FELDAN ANNOUNCES A PUBLICATION IN NATURE COMMUNICATIONS

Using the Feldan Shuttle technology, our team and collaborators have successfully demonstrated for the first time, the feasibility of base editing in non-human primate lungs. This study provides in vivo proof-of-concept of functional delivery to large animal lung cells and highlights the therapeutic potential of the Feldan Shuttle as pulmonary delivery agent to develop treatment for lung diseases. Feldan would like to thank collaborators at University of Iowa, UC Davis, Johns Hopkins University School of Medicine, Harvard University, Integrated DNA Technologies, and TransBIOTech for this accomplishment. Read full article here: https://www.nature.com/articles/s41467-023-43904-w